HIGHLIGHTS
- What: The aims of this study are to estimate associations between latent measures of healthcare Healthcare access factors in breast cancer access with timeliness of diagnosis, treatment initiation, and treatment completion; to estimate associations between healthcare access with receipt of the OncotypeDx genomic test; and_(3) to describe differences in care timeliness between black and non-black patients. The study provides additional evidence that travel burden may affect treatment timeliness within racially diverse patient populations and more geographically dispersed states as well.
- Who: Matthew R. Dunn and colleagues from the Department of Epidemiology, University of . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.